Clinical Trials Logo

Active Melanoma Brain Metastases clinical trials

View clinical trials related to Active Melanoma Brain Metastases.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02230306 Terminated - Clinical trials for Active Melanoma Brain Metastases

Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases

CoBRIM-B
Start date: February 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of the combination of vemurafenib with cobimetinib in patients with active melanoma brain metastases.